353 related articles for article (PubMed ID: 19341863)
1. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension.
Quarck R; Nawrot T; Meyns B; Delcroix M
J Am Coll Cardiol; 2009 Apr; 53(14):1211-8. PubMed ID: 19341863
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value.
Scognamiglio G; Kempny A; Price LC; Alonso-Gonzalez R; Marino P; Swan L; D' Alto M; Hooper J; Gatzoulis MA; Dimopoulos K; Wort SJ
Heart; 2014 Sep; 100(17):1335-41. PubMed ID: 24790070
[TBL] [Abstract][Full Text] [Related]
4. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Reesink HJ; van der Plas MN; Verhey NE; van Steenwijk RP; Kloek JJ; Bresser P
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):510-6. PubMed ID: 17258590
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic variables and clinical features correlated with serum uric acid in patients with pulmonary arterial hypertension.
Jiang X; Han ZY; Wang Y; Xu XQ; Ma CR; Wu Y; Pan L; Jing ZC
Chin Med J (Engl); 2008 Dec; 121(24):2497-503. PubMed ID: 19187585
[TBL] [Abstract][Full Text] [Related]
6. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery.
Nagasaki T; Inaba M; Shirakawa K; Hiura Y; Tahara H; Kumeda Y; Ishikawa T; Ishimura E; Nishizawa Y
Biomed Pharmacother; 2007; 61(2-3):167-72. PubMed ID: 17383146
[TBL] [Abstract][Full Text] [Related]
8. Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study.
Vizza CD; Badagliacca R; Sciomer S; Poscia R; Battagliese A; Schina M; Agati L; Fedele F
Cardiology; 2006; 106(3):168-73. PubMed ID: 16645271
[TBL] [Abstract][Full Text] [Related]
9. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
[TBL] [Abstract][Full Text] [Related]
10. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of C-reactive protein in long-term care patients requiring prolonged mechanical ventilation.
Sierros V; Fleming R; Cascioli M; Brady T
Chron Respir Dis; 2009; 6(3):149-55. PubMed ID: 19643829
[TBL] [Abstract][Full Text] [Related]
12. Biological serum markers in the management of pediatric pulmonary arterial hypertension.
Van Albada ME; Loot FG; Fokkema R; Roofthooft MT; Berger RM
Pediatr Res; 2008 Mar; 63(3):321-7. PubMed ID: 18287971
[TBL] [Abstract][Full Text] [Related]
13. Asthma is an independent risk for elevation of plasma C-reactive protein levels.
Kasayama S; Tanemura M; Koga M; Fujita K; Yamamoto H; Miyatake A
Clin Chim Acta; 2009 Jan; 399(1-2):79-82. PubMed ID: 18838067
[TBL] [Abstract][Full Text] [Related]
14. Survival in schistosomiasis-associated pulmonary arterial hypertension.
dos Santos Fernandes CJ; Jardim CV; Hovnanian A; Hoette S; Dias BA; Souza S; Humbert M; Souza R
J Am Coll Cardiol; 2010 Aug; 56(9):715-20. PubMed ID: 20723801
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
16. Predictors of outcome in chronic thromboembolic pulmonary hypertension.
Bonderman D; Skoro-Sajer N; Jakowitsch J; Adlbrecht C; Dunkler D; Taghavi S; Klepetko W; Kneussl M; Lang IM
Circulation; 2007 Apr; 115(16):2153-8. PubMed ID: 17420352
[TBL] [Abstract][Full Text] [Related]
17. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina.
Li JJ; Zhang YP; Yang P; Zeng HS; Qian XW; Zhang CY; Zhu CG; Li J; Nan JL
Coron Artery Dis; 2008 Aug; 19(5):293-7. PubMed ID: 18607165
[TBL] [Abstract][Full Text] [Related]
18. Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension.
Henkens IR; Van Wolferen SA; Gan CT; Boonstra A; Swenne CA; Twisk JW; Kamp O; van der Wall EE; Schalij MJ; Vonk-Noordegraaf A; Vliegen HW
Am J Cardiol; 2009 May; 103(10):1451-6. PubMed ID: 19427445
[TBL] [Abstract][Full Text] [Related]
19. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells.
Damås JK; Otterdal K; Yndestad A; Aass H; Solum NO; Frøland SS; Simonsen S; Aukrust P; Andreassen AK
Circulation; 2004 Aug; 110(8):999-1005. PubMed ID: 15302794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
